Literature DB >> 27406969

Skin testing, graded challenge, and desensitization to von Willebrand factor (VWF) products in type III von Willebrand disease (VWD).

Craig D Platt1, Loren D'Angelo2, Ellis J Neufeld2, Ana Dioun Broyles3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27406969      PMCID： PMC5802411          DOI： 10.1016/j.jaip.2016.05.017

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


× No keyword cloud information.
  8 in total

Review 1.  Allergy to monoclonal antibodies: cutting-edge desensitization methods for cutting-edge therapies.

Authors:  David I Hong; Lora Bankova; Katherine N Cahill; Timothy Kyin; Mariana C Castells
Journal:  Expert Rev Clin Immunol       Date:  2012-01       Impact factor: 4.473

2.  How I treat inhibitors in haemophilia.

Authors:  M Makris; C R M Hay; A Gringeri; R D'Oiron
Journal:  Haemophilia       Date:  2012-07       Impact factor: 4.287

3.  The challenging management of a child with type 3 von Willebrand disease and antibodies to von Willebrand factor.

Authors:  H Pergantou; P Xafaki; E Adamtziki; P Koletsi; A Komitopoulou; H Platokouki
Journal:  Haemophilia       Date:  2012-05       Impact factor: 4.287

Review 4.  Desensitization to antibiotics in children.

Authors:  Josefina R Cernadas
Journal:  Pediatr Allergy Immunol       Date:  2012-09-11       Impact factor: 6.377

5.  Polysorbate 80 hypersensitivity.

Authors:  W B Shelley; N Talanin; E D Shelley
Journal:  Lancet       Date:  1995-05-20       Impact factor: 79.321

Review 6.  Alloantibodies in von Willebrand disease.

Authors:  Paula D James; David Lillicrap; Pier M Mannucci
Journal:  Blood       Date:  2013-01-07       Impact factor: 22.113

Review 7.  The pathophysiology of von Willebrand disease: therapeutic implications.

Authors:  Reinhard Schneppenheim
Journal:  Thromb Res       Date:  2011       Impact factor: 3.944

Review 8.  von Willebrand disease: advances in pathogenetic understanding, diagnosis, and therapy.

Authors:  David Lillicrap
Journal:  Blood       Date:  2013-09-24       Impact factor: 22.113
  8 in total
  1 in total

1.  Successful Desensitization of a Patient with Possible IgE-Mediated Anaphylactic Reaction to FVIII/VWF Concentrate.

Authors:  Burcin Beken; Velat Celik; Pinar Gokmirza Ozdemir; Tuba Eren; Mehtap Yazicioglu
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2019-06-17       Impact factor: 1.349
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.